Amneal Pharmaceuticals, Inc. (AMRX) は上場企業です ヘルスケア セクターの Drug Manufacturers - Specialty & Generic 業界で事業展開. 本社所在地は Bridgewater, NJ, アメリカ. 現CEOは Chirag K. Patel.
AMRX を有する IPO日 2018-05-07, 8,300 名の正社員, に上場 NASDAQ Global Select, 時価総額 $4.13B.
Amneal Pharmaceuticals, Inc. is a diversified pharmaceutical company that develops, manufactures, and distributes generic and specialty pharmaceutical products across multiple dosage forms and therapeutic areas. The company operates through three segments: Generics, which produces complex oral solids, injectables, ophthalmics, and other formulations; Specialty, which markets branded products for central nervous system disorders, endocrinology, and parasitic infections including brands like Rytary and Unithroid; and AvKARE, which supplies pharmaceuticals and medical products to government agencies and the Department of Defense. Amneal serves customers through wholesalers, distributors, hospitals, and retail pharmacies across the United States, India, Ireland, and internationally. Founded in 2002 and headquartered in Bridgewater, New Jersey, the company has established itself as a significant player in both the generic and specialty pharmaceutical markets.
